Pharmacological Treatments for Acute Respiratory Distress Syndrome

Pharmacological Treatments for Acute Respiratory Distress Syndrome is organized by American Association of Critical-Care Nurses (AACN).

Expires: Jul 01, 2019

Topics: Pharmacology, Pulmonary

Credits:
Contact Hours: 1.00
CERP A: 1.00
Pharmacology Hours: 1.00

Activity Summary:
The term acute respiratory distress syndrome (ARDS) was first coined in 1967 to define a clinical syndrome categorized by progressive hypoxemia, dyspnea, and increased work of breathing that is unresponsive to standard respiratory therapy. Acute respiratory distress syndrome presents as acute respiratory failure with noncardiogenic pulmonary edema and severe hypoxemia. Historically, this syndrome of potentially fatal pulmonary complications described in critically ill patients was further divided into acute lung injury (ALI) and ARDS, with ALI representing a more mild presentation of ARDS. 2 More recently, the concept of ALI has been replaced with mild, moderate, and severe classifications for ARDS.

Objectives:
• Define the phases of acute lung injury that lead to acute respiratory distress syndrome (ARDS).
• Identify advantages and disadvantages of current treatment strategies for ARDS.
• Examine emerging treatment strategies for ARDS.

Additional details will be posted as soon as they are available.